Frequency News and Research

RSS

Grant introduces new range of digital, analogue ultrasonic benchtop baths

Grant Instruments, a world-renowned supplier of scientific, life sciences and data acquisition products, has unveiled an advanced range of high quality, robust, fully-featured digital and analogue ultrasonic benchtop baths. The baths are designed to meet the growing need for reliable ultrasonic cleaning in laboratories and across pharmaceutical, medical, healthcare and industrial applications.

23 Jun 2010

Children who experience maltreatment more likely to have frequent headaches as adults, say scientists

Children who experience maltreatment such as emotional, physical and sexual abuse are more likely to experience frequent headaches, including chronic migraine, as adults, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week.

23 Jun 2010

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.

21 Jun 2010

Report: Proper contact lens replacement schedule compliance associated with better vision, comfort

A report published in the journal Optometry & Vision Science demonstrated that patients who replaced their silicone hydrogel contact lenses according to the manufacturer recommended replacement frequency experienced better comfort and vision at the end of the day than non-compliant patients. The analysis was part of a larger study sponsored by CIBA VISION, which was developed to investigate contact lens replacement schedule compliance.

18 Jun 2010

Research shows JIA patients have increased risk of cancer

Biologics-na-ve Juvenile Idiopathic Arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.

18 Jun 2010

New legislation will impede use of MRI in medical research

Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.

17 Jun 2010

Scientists identify symptoms associated with late-onset hypogonadism

Scientists have for the first time identified the symptoms associated with what has been termed late-onset hypogonadism or 'male menopause' caused by a reduction in testosterone production in ageing men.

17 Jun 2010

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.

17 Jun 2010

Prevention, awareness of enlarged prostate can help save lives

We live in a country of excess where size often matters most. Supersize, grande, max, king size - but is bigger always better? Certainly not when it comes to male health and an enlarged prostate.

16 Jun 2010

Eating Mediterranean-style diet reduces heart disease risk: Research

A study of twins shows that even with genes that put them at higher risk of cardiovascular disease, eating a Mediterranean-style diet can improve heart function, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

16 Jun 2010

Cytokine PharmaSciences completes misoprostol vaginal insert Phase II study

Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.

16 Jun 2010

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.

15 Jun 2010

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Raptor Pharmaceutical Corp., announced that the European Medicines Agency's ("EMA") Committee for Orphan Medicinal Products ("COMP") has issued a positive opinion recommending orphan medicinal product designation for DR Cysteamine for the potential treatment of cystinosis.

15 Jun 2010

AMA's National Health Insurer Report Card helps improve claims processing performance

The American Medical Association today announced that one in five medical claims are processed inaccurately by health insurers, according to the AMA's third annual check-up of the nation's commercial health insurers and the systems they use to manage and pay claims. This was the key finding of the AMA's 2010 National Health Insurer Report Card, which for the first time, benchmarked the overall claims processing accuracy of the nation's largest health insurers.

15 Jun 2010

CT angiography not necessary in patients suspected with pulmonary embolism

A new study suggests that computed tomography (CT) angiography might be unnecessary in many patients suspected of having pulmonary embolism (PE), based on the results of risk assessment analysis. PE risk assessment could help reduce radiation exposure and costs associated with CT angiography. The results of the study appear in the online edition and August print issue of the journal Radiology.

15 Jun 2010

SCS may be able to modulate PD symptoms: Study

A new study from Rhode Island Hospital indicates that spinal cord stimulation may be able to modulate Parkinson's disease symptoms. The lead author will present the findings at the 2010 American Society for Stereotactical and Functional Neurosurgery Biennial Meeting, June 14-16 in New York City.

15 Jun 2010

Medidata Solutions introduces Grants Manager 3.0 to select correct procedure for budgeting in trial

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today introduced Medidata Grants Manager 3.0, the newest version of its trial budgeting application in use today by many of the innovative clinical research sponsors in the life sciences industry. Now offered as a web-based solution, Grants Manager 3.0 enables users to build clinical trial grant budgets and benchmark them against Medidata's unique PICAS database of negotiated trial costs without the need to install software.

14 Jun 2010

Children get MRI tests for reasons unrelated to benign anomalies: Study

Pediatricians whose patients undergo "routine" brain MRIs need a plan to deal with findings that commonly reveal unexpected-but-benign anomalies that are unlikely to cause any problem, reports a research team led by Johns Hopkins Children's Center investigators.

14 Jun 2010

ARBs increase risk of cancer: Study

University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs).

14 Jun 2010

National MS Society commits over $2.4M to support 7 CCSVI research projects

Over $2.4 million has been committed by the National MS Society (USA) and the MS Society of Canada to support 7 new research projects focusing on the role of CCSVI in MS.

14 Jun 2010

Frequency News and Research

Grant introduces new range of digital, analogue ultrasonic benchtop baths

Children who experience maltreatment more likely to have frequent headaches as adults, say scientists

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Report: Proper contact lens replacement schedule compliance associated with better vision, comfort

Research shows JIA patients have increased risk of cancer

New legislation will impede use of MRI in medical research

Scientists identify symptoms associated with late-onset hypogonadism

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Prevention, awareness of enlarged prostate can help save lives

Eating Mediterranean-style diet reduces heart disease risk: Research

Cytokine PharmaSciences completes misoprostol vaginal insert Phase II study

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

AMA's National Health Insurer Report Card helps improve claims processing performance

CT angiography not necessary in patients suspected with pulmonary embolism

SCS may be able to modulate PD symptoms: Study

Medidata Solutions introduces Grants Manager 3.0 to select correct procedure for budgeting in trial

Children get MRI tests for reasons unrelated to benign anomalies: Study

ARBs increase risk of cancer: Study

National MS Society commits over $2.4M to support 7 CCSVI research projects

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News